Filing Details
- Accession Number:
- 0001968202-24-000122
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-19 16:01:37
- Reporting Period:
- 2024-08-15
- Accepted Time:
- 2024-08-19 16:01:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189014 | A Christine Poon | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-08-15 | 10,838 | $413.33 | 13,010 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-08-15 | 1,012 | $1,155.72 | 11,998 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-15 | 2,368 | $1,156.30 | 9,630 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-15 | 1,560 | $1,157.33 | 8,070 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-15 | 212 | $1,158.02 | 7,858 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-15 | 5,352 | $1,159.56 | 2,506 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-15 | 234 | $1,160.45 | 2,272 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-08-15 | 100 | $1,161.32 | 2,172 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-08-15 | 10,838 | $0.00 | 10,838 | $413.33 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- Represents volume-weighted average price of sales of 1,012 shares of Company stock on August 15, 2024 at prices ranging from $1,155.38 to $1,155.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 2,368 shares of Company stock on August 15, 2024 at prices ranging from $1,156.04 to $1,156.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 1,560 shares of Company stock on August 15, 2024 at prices ranging from $1,157.02 to $1,157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 212 shares of Company stock on August 15, 2024 at prices ranging from $1,158.01 to $1,158.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 5,352 shares of Company stock on August 15, 2024 at prices ranging from $1,159.18 to $1,159.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 234 shares of Company stock on August 15, 2024 at prices ranging from $1,160.10 to $1,160.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.